We also evaluated a possible correlation of sHLA-G with the level of immunoregulatory and anti-inflammatory cytokine IL-10, pro-inflammatory cytokine IL-6, and their ratio (IL-10/IL-6), and the association of sHLA-G with the survival of glioma patients. This evidence concerns the gene IL6 and central nervous system cancer.